Literature DB >> 28878599

Clinical Importance of Histopathological Inflammation in Patients with Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Prospective Study of 222 Patients.

Thibault Meert1,2, Evert Baten1,2, Koenraad van Renterghem1,3,2.   

Abstract

OBJECTIVE: To investigate the relationship between the severity of histopathological prostatic inflammation with lower urinary tract symptoms and prostate specific antigen (PSA) levels.
METHODS: We prospectively included 222 consecutive patients eligible for transurethral resection of the prostate in a non-academic referral center by a single surgeon. Patients with proven urinary tract infection or prostate cancer were excluded. Preoperative assessment included PSA levels, International Prostate Symptom Score (IPSS), mean peak flow, mean resected prostate weight and post-residual volume. Finally, the presence and severity of inflammation was determined histopathologically.
RESULTS: Mean patient age was 69.1 ± 8.6 years with mean preoperative PSA levels of 4.7 ± 5.4 ng/mL and IPSS of 15.7 ± 6.9. Mean peak flow was 10.7 ± 6.5 ml/s and the mean resected prostate weight 39.4 ± 27.3 g. Positive correlations between PSA (log) and prostate weight (r = 0.54, p < 0.001) and between PSA (log) and active (r = 0.30, p < 0.0001) and chronic inflammation (r = 0.19, p = 0.005) were observed. No correlations were found between IPSS and PSA (log) (r = -0.14, p = 0.040) or between IPSS and active inflammation (p = 0.659) or chronic inflammation (p = 0.125).
CONCLUSION: The study showed a weak correlation between PSA and the active or chronic inflammation. It also showed that there was no correlation between the active or chronic histopathological inflammation and IPSS.

Entities:  

Keywords:  Benign prostatic hyperplasia; Benign prostatic hypertrophy; Prostate; Prostate specific antigen

Year:  2017        PMID: 28878599      PMCID: PMC5582431          DOI: 10.1159/000447170

Source DB:  PubMed          Journal:  Curr Urol        ISSN: 1661-7649


  16 in total

1.  Chronic prostatitis: a thorough search for etiologically involved microorganisms in 1,461 patients.

Authors:  W Weidner; H G Schiefer; H Krauss; C Jantos; H J Friedrich; M Altmannsberger
Journal:  Infection       Date:  1991       Impact factor: 3.553

2.  Role of inflammation in benign prostatic hyperplasia development among Han Chinese: A population-based and single-institutional analysis.

Authors:  Jimeng Hu; Limin Zhang; Lujia Zou; Mengbo Hu; Jie Fan; Yehua Cai; Gang Xu; Jie Fang; Qiang Ding; Haowen Jiang
Journal:  Int J Urol       Date:  2015-08-27       Impact factor: 3.369

3.  Clinical relevance of transurethral resection of the prostate in "asymptomatic" patients with an elevated prostate-specific antigen level.

Authors:  Koenraad van Renterghem; Gommert Van Koeveringe; Ruth Achten; Philip Van Kerrebroeck
Journal:  Eur Urol       Date:  2007-03-28       Impact factor: 20.096

4.  Intraprostatic inflammation is positively associated with serum PSA in men with PSA <4 ng ml(-1), normal DRE and negative for prostate cancer.

Authors:  M H Umbehr; B Gurel; T J Murtola; S Sutcliffe; S B Peskoe; C M Tangen; P J Goodman; I M Thompson; S M Lippman; M S Lucia; H L Parnes; C G Drake; W G Nelson; A M De Marzo; E A Platz
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-05-05       Impact factor: 5.554

5.  Influence of asymptomatic histologic prostatitis on serum prostate-specific antigen: a prospective study.

Authors:  Lucila Heloisa Simardi; Marcos Tobias-MacHado; Guilherme Tommasi Kappaz; Patricia Taschner Goldenstein; Jeannette M Potts; Eric Roger Wroclawski
Journal:  Urology       Date:  2004-12       Impact factor: 2.649

6.  Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.

Authors:  T A Stamey; N Yang; A R Hay; J E McNeal; F S Freiha; E Redwine
Journal:  N Engl J Med       Date:  1987-10-08       Impact factor: 91.245

Review 7.  The role of inflammation in lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) and its potential impact on medical therapy.

Authors:  Vincenzo Ficarra; Marta Rossanese; Michele Zazzara; Gianluca Giannarini; Maria Abbinante; Riccardo Bartoletti; Vincenzo Mirone; Francesco Scaglione
Journal:  Curr Urol Rep       Date:  2014-12       Impact factor: 3.092

8.  Prostate Biopsy Markers of Inflammation are Associated with Risk of Clinical Progression of Benign Prostatic Hyperplasia: Findings from the MTOPS Study.

Authors:  Kathleen C Torkko; R Storey Wilson; Elizabeth E Smith; John W Kusek; Adrie van Bokhoven; M Scott Lucia
Journal:  J Urol       Date:  2015-03-28       Impact factor: 7.450

9.  Inflammation in prostate biopsies of men without prostatic malignancy or clinical prostatitis: correlation with total serum PSA and PSA density.

Authors:  P H Schatteman; L Hoekx; J J Wyndaele; W Jeuris; E Van Marck
Journal:  Eur Urol       Date:  2000-04       Impact factor: 20.096

10.  The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial.

Authors:  J Curtis Nickel; Claus G Roehrborn; Michael P O'Leary; David G Bostwick; Matthew C Somerville; Roger S Rittmaster
Journal:  Eur Urol       Date:  2007-11-20       Impact factor: 20.096

View more
  1 in total

1.  Improvement of urinary tract symptoms and quality of life in benign prostate hyperplasia patients associated with consumption of a newly developed whole tomato-based food supplement: a phase II prospective, randomized double-blinded, placebo-controlled study.

Authors:  Luigi Cormio; Beppe Calò; Ugo Falagario; Manuela Iezzi; Alessia Lamolinara; Paola Vitaglione; Giovanni Silecchia; Giuseppe Carrieri; Vincenzo Fogliano; Stefano Iacobelli; Pier Giorgio Natali; Mauro Piantelli
Journal:  J Transl Med       Date:  2021-01-06       Impact factor: 5.531

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.